|
|||||
|
US FDA hs Indicated that they plan to closely monitor the sale of genetic tests directly to consumers, Te FDA Friday told this to five companies involved in the business — including two in the Bay Area — their products are medical devices that require the government’s approval. Among the companies the US Food . . . → Read More: FDA to monitor genetic testing February 25, 2010 — US The National Institutes of Health (NIH) and the US Food and Drug Administration (FDA) have announced a new partnership to speed the biomedical advances their processing time and movement through the regulatory process required for clinical application. The new partnership was made public yesterday in a briefing on the . . . → Read More: NIH and FDA Collaborate to Speed Therapies Nine contracts worth up to $400 million have been awarded by the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) to develop more effective tests and devices to measure how much radiation people absorb after a nuclear or radiological incident. The contracts’ first phase will be worth $35 . . . → Read More: Contracts to Develop Field Tests for Radiation Exposures 18th December 2009 WASHINGTON, — Significant changes are needed in healthcare reform legislation to prevent senior citizens and the disabled from facing a difficult time obtaining homecare products through Medicare. The current legislation would likely prevent or delay many Medicare beneficiaries from receiving critical medical equipment that helps sustain their lives and allows them . . . → Read More: Healthcare Bills Will Hamper Medicare Services for Seniors and the Disabled 17th December 2009 New Brunswick, NJ USA The Dr. Paul Janssen Award for Biomedical Research has opened the 2010 call for nominations. The $100,000 Award recognizes individuals whose efforts have made significant transformational contributions towards the improvement of human health. Nomination forms are available at www.pauljanssenaward.com and will be accepted until February 15, 2010. . . . → Read More: Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 14th December 2009 Madison USA: Kevin Conroy the CEO of Madison-based company, Exact Sciences Corp. says the number of deaths from colon cancer could be reduced significantly if people had an easy, reliable method of detecting the disease in its early stage. Although a colonoscopy is very effective, the invasive nature of the procedure . . . → Read More: Company wants to ease colon cancer detection WASHINGTON — Doctors and hospitals should stop using a device from Steris Corp. to sterilize surgical tools after reports of malfunction, according to the Food and Drug Administration. The Mentor-based company’s modified SS1 sterilizer device has not been cleared as safe and effective. Users have reported problems that could result in patients becoming infected . . . → Read More: FDA Warns of Problems With Steris Corp. Sterilization Device 12th August 2009 Minnesota USA – The University of Minnesota-bred start-up, based on the regenerative tissue work of Dr. Doris Taylor, will be called Miromatrix Inc. (It seems like any biomedical company worth its salt must have an “x” in its name). The company, which is developing a way to grow transplant organs in labs, . . . → Read More: University of Minnesota Organ Transplant Spin-Off moves Closer to Reality KLAS issues its yearly Top 20 mMedical Equipments Awards for 2009 . Among the CT the top vote went to Toshiba Aquilion 64, Digital XRay went to Shimadzu RAD Speed, Magnetic Resonance (MR) – 1.5T went to Toshiba Vantage 1.5T MR. Mammography Digital went to GE Senographe DS. For Smart pumps the top voted was B Braun . . . → Read More: 2009 Top 20 Best in KLAS Awards: Medical Equipment 7th December 2009 : Mexico City has announced plans for what it hopes will be a world-class centre for biomedical and nano-medical research. The new research center will be called “Campus Biometropolis”, the city hopes to attract investment and become an “engine for the transformation” of Mexico’s economy. For the pharma industry, the news . . . → Read More: World-class medical research hub planned in Mexico Graph Source PMR Publications 2nd December 2009 : The pharmaceutical market in Central and Eastern Europe is dominated by generic drugs. This subdivision was worth €17.2bn in 2008 and is expected to develop by around 14% per annum between 2009 and 2011. The growth rate of the innovative drug market, which was worth . . . → Read More: Generics will continue domination on the pharmaceutical market in Europe until 2011 1st December 2009 : Lucrative opportunities await manufacturers in the European wireless patient monitoring devices market, particularly in the wireless assisted living devices segment. This segment is growing at a rapid pace. The primary reason for this growth is rising awareness levels among an ageing population about devices that help in attaining a better . . . → Read More: Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices in Europe BLOOMINGTON, Minn., Nov. 29 /PRNewswire/ — Acuo Technologies, developers of high-performance medical image management software, data migration tools and services have announced a new product called AcuoShare that allows image sharing across the networks of hospitals, clinics & affiliates. The AcuoShare solution is based on the versatile Acuo Technologies DICOM Services Grid(TM) Software. The . . . → Read More: Acuo Technologies Enables Sharing of Imaging Studies Securely and Affordably Researchers from Whitehead Institute for Biomedical Research say they’ve developed a new type of genetic screen for human cells to pinpoint specific genes and proteins used by pathogens. The identification of such factors could aid the future development of new therapeutics to combat infectious disease. Their paper, titled “Haploid genetic screens in human cells . . . → Read More: Scientists Use Knockout Cells to Discover New Genes Involved in Viral and Bacterial Resistance SINGAPORE, Nov. 20 Singapore announced on Friday that it will inject 36 million Singapore dollars (25.9 million U.S. dollars) into new programs to give a greater push to its growing medical technology industry locally. The Agency for Science, Technology and Research (A*STAR), Singapore’s leading research agency said that the programs included the collaboration between . . . → Read More: Singapore ramps up biomedical sciences effort |
|||||
|
Copyright © 2012 Biomed Middle East - All Rights Reserved |
|||||
